logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
I

Ian F. Tannock

Princess Margaret Cancer Centre and University of Toronto

111H-index
616Paper Count
6.2WCitation Count
Published Papers 182
Publication Date
logo
Adherence of Published Randomized Phase 3 Cancer Trials to Principles Proposed by Common-Sense Oncology
errEuropean Journal of Cancer
IF7.1
err2025-10-02
err0
PREAI
errOmar Abdihamid; Bishal Gyawali; Christopher M. Booth; Elizabeth A Eisenhauer; Wilma M. Hopman; Brian Shkabari; Dario Trapani; Haydee C. Verduzco-Aguirre; Brooke E. Wilson; Ian F. Tannock
errShare
errSave
Non-financial conflicts of interest
errNature Reviews Clinical Oncology
IF82.2
err2025-09-03
err0
PREAI
errSaroj Niraula; Ian F. Tannock
errShare
errSave
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer
errlancet oncology
IF0
err2025-09-01
err0
PREAI
errIan F Tannock; Madeline Lee Pe; Christopher M Booth; Michael Brundage; Nathan I Cherny; Corneel Coens; Elizabeth A Eisenhauer; Jan Geissler; Johannes M Giesinger; Bishal Gyawali; Sjoukje F Oosting; Gregory R Pond; Jaap C Reijneveld; Enrique Soto-Perez-de-Celis; Michelle Tregear; Winette T A van der Graaf
errShare
errSave
Clarifying the role of SONIA: supporting academic evidence on CDK4/6 inhibitor timing
errNature Reviews Clinical Oncology
IF82.2
err2025-07-28
err0
PREAI
errAvi Petroff; Ian F. Tannock; Daniel A. Goldstein
errShare
errSave
Guidance for discussants of randomized cancer trials at major meetings
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2025-05-01
err0
PREAI
errEisenhauer, Elizabeth A.; Abdihamid, Omar; Booth, Christopher M.; Cherny, Nathan; Fojo, Antonio T.; Gyawali, Bishal; Marini, Bernard L.; Mohyuddin, Ghulam Rehman; Pe, Madeline; Pond, Gregory R.; Soto-Perez-de-Celis, Enrique; Tannock, Ian F.; Trapani, Dario; Tregear, Michelle; van der Graaf, Winette T. A.; Wilson, Brooke E.
errShare
errSave
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring
errJAMA NETWORK OPEN
IF9.7
err2025-01-22
err0
errOAAI
errMeirson, Tomer; Ofer, Jonathan; Zimhony-Nissim, Noa; Bareket-Samish, Avital; Markel, Gal; Neiman, Victoria; Cherny, Nathan; Goldstein, Daniel A.; Gyawali, Bishal; Tannock, Ian; Rosenbaum, Eli
errShare
errSave
RETRACTION: Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors (Retraction of Vol 18, Pg 347, 2016)
errNEOPLASIA
IF7.7
err2024-05-01
err0
errOAAI
errTan, Qian; Wang, Marina; Yu, Man; Zhang, Junyan; Bristow, Robert G.; Hill, Richard P.; Tannock, Ian F.
errShare
errSave
The Lancet Commission on prostate cancer: planning for the surge in cases
errLANCET
IF88.5
err2024-04-01
err57
errOAAI
errJames, Nicholas; Tannock, Ian; N'Dow, James; Feng, Felix; Gillessen, Silke; Ali, Syed Adnan; Trujillo, Blanca; Al-Lazikani, Bissan; Attard, Gerhardt; Bray, Freddie; Comperat, Eva; Eeles, Ros; Fatiregun, Omolara; Grist, Emily; Halabi, Susan; Haran, Aine; Herchenhorn, Daniel; Hofman, Michael S.; Jalloh, Mohamed; Loeb, Stacy; Macnair, Archie; Mahal, Brandon; Mendes, Larissa; Moghul, Masood; Moore, Caroline; Morgans, Alicia; Morris, Michael; Murphy, Declan; Murthy, Vedang; Nguyen, Paul L.; Padhani, Anwar; Parker, Charles; Rush, Hannah; Sculpher, Mark; Soule, Howard; Sydes, Matthew R.; Tilki, Derya; Tunariu, Nina; Villanti, Paul; Xie, Li-Ping
errShare
errSave
RETRACTION: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy (Retraction of Vol 112, Pg 832, 2015)
errBRITISH JOURNAL OF CANCER
IF6.8
err2024-03-20
err0
errOAAI
errTan, Q.; Joshua, A. M.; Saggar, J. K.; Yu, M.; Wang, M.; Kanga, N.; Zhang, J. Y.; Chen, X.; Wouters, B. G.; Tannock, I. F.
errShare
errSave
Cell proliferation, drug distribution and therapeutic effects in relation to the vascular system of solid tumours
errBRITISH JOURNAL OF CANCER
IF6.8
err2022-12-23
err3
errOAAI
errTannock, Ian F.; Gordon Steel, G.
errShare
errSave
Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access
errNATURE MEDICINE
IF50
err2022-10-06
err34
errOAAI
errHirsch, Ian; Goldstein, Daniel A.; Tannock, Ian F.; Butler, Marcus O.; Gilbert, Duncan C.
errShare
errSave
The dosing of ibrutinib and related Bruton's tyrosine kinase inhibitors: eliminating the use of brute force COMMENT
errBLOOD ADVANCES
IF7.1
err2022-08-30
err5
errOAAI
errRatain, Mark J.; Tannock, Ian F.; Lichter, Allen S.
errShare
errSave
Priorities for cancer research in low- and middle-income countries: a global perspective
errNATURE MEDICINE
IF50
err2022-04-19
err159
errOAAI
errPramesh, C. S.; Badwe, Rajendra A.; Bhoo-Pathy, Nirmala; Booth, Christopher M.; Chinnaswamy, Girish; Dare, Anna J.; de Andrade, Victor Piana; Hunter, David J.; Gopal, Satish; Gospodarowicz, Mary; Gunasekera, Sanjeeva; Ilbawi, Andre; Kapambwe, Sharon; Kingham, Peter; Kutluk, Tezer; Lamichhane, Nirmal; Mutebi, Miriam; Orem, Jackson; Parham, Groesbeck; Ranganathan, Priya; Sengar, Manju; Sullivan, Richard; Swaminathan, Soumya; Tannock, Ian F.; Tomar, Vivek; Vanderpuye, Verna; Varghese, Cherian; Weiderpass, Elisabete
errShare
errSave
Improving access to immunotherapy in low- and middle-income countries
errANNALS OF ONCOLOGY
IF65.4
err2022-04-01
err21
errOAAI
errPatel, A.; Goldstein, D. A.; Tannock, I. F.
errShare
errSave
How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy
errANNALS OF ONCOLOGY
IF65.4
err2021-07-01
err23
errOAAI
errFundytus, A.; Booth, C. M.; Tannock, I. F.
errShare
errSave
The European Union and personalised cancer medicine
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2021-06-01
err5
PREAI
errHickman, John A.; Tannock, Ian F.; Meheus, Lydie; Hutchinson, Lisa
errShare
errSave
Have investigators forgotten how to write?
errANNALS OF ONCOLOGY
IF65.4
err2021-04-01
err4
errOAAI
errTannock, I. F.
errShare
errSave
Cautionary tails
errANNALS OF ONCOLOGY
IF65.4
err2021-01-01
err0
errOAAI
errDel Paggio, J. C.; Tannock, I. F.
errShare
errSave
Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets
errJCO GLOBAL ONCOLOGY
IF3
err2020-11-01
err27
errOAAI
errPatel, Amol; Tannock, Ian F.; Srivastava, Priyanka; Biswas, Bivas; Gupta, Vineet Govinda; Batra, Atul; Bhethanabhotla, Sainath; Pramanik, Raja; Mahindru, Shubh; Tilak, Tvsvgk; Das, Chandan Krishna; Mehta, Prashant
errShare
errSave
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration -resistant prostate cancer y
errANNALS OF ONCOLOGY
IF65.4
err2020-07-01
err13
errOAAI
errHalabi, S.; Dutta, S.; Tangen, C. M.; Rosenthal, M.; Petrylak, D. P.; Thompson, I. M., Jr.; Chi, K. N.; De Bono, J. S.; Araujo, J. C.; Logothetis, C.; Eisenberger, M. A.; Quinn, D. I.; Fizazi, K.; Morris, M. J.; Higano, C. S.; Tannock, I. F.; Small, E. J.; Kelly, W. K.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
D
David J. Hunter
H-index: 204 · Papers: 2.5K
M
Mark A. Rubin
H-index: 186 · Papers: 1.5K
M
Murray F. Brennan
H-index: 172 · Papers: 1.2K
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
View more